VYNE Competitors & Alternatives
Compare Vyne Therapeutics Inc with similar stocks in the same industry
Biotechnology
VYNE
Main Stock$28.56
Tradestie Score
39
Market Cap
$8.64M
Revenue Growth
-0.6%
Analyst Upside
-93.0%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.82
|
$97.42M | - | 45 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$6.47
|
$85.47M | - | 36 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.42
|
$84.52M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.52
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.61
|
$67.94M | - | 34 | Compare |
|
INUV
Inuvo, Inc.
|
$0.71
|
$50.94M | - | 51 | Compare |
|
DARE
Dare Bioscience, Inc. Common Stock
|
$0.80
|
$28.98M | - | 51 | Compare |
|
TTOO
TTOO
|
- | - | - | - | Compare |
|
MBAI
MBAI
|
$8.04
|
- | - | 32 | Compare |
|
DCOY
DCOY
|
$3.11
|
- | - | 47 | Compare |
More VYNE Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
242 stocks in this industry